Table 2 Results of statistical analyses (expected and observed frequency, related risk of occurrence of malignancies of various site of origin) in MM/CFA families
Tumour site1 | Observed frequency (OF %) | Expected frequency (EF %) | Relative risk (RR, CI 95%) |
|---|---|---|---|
breast 2 | Â | Â | Â |
   ≤ 55 MM/CFA | 142 (10.6) | 5.68 (4.3) | 3.256 (CI 95% 0.95–6.8)4 |
   >55 MM/CFA | 132 (9.8) | 11.35 (8.6) | 1.145 (CI 95% 0.54–2.45) |
lungs | Â | Â | Â |
   males | 17 (5.6) | 12.57 (4.1) | 1.352 (CI 95% 0.63–2.934) |
   females | 4 (1.3) | 2.95 (0.9) | 1.358 (CI 95% 0.258–7.678) |
colon | Â | Â | Â |
   males | 8 (2.6) | 5.17 (1.7) | 1.547 (CI 95% 0.47–5.306) |
   females | 7 (2.2) | 4.59 (1.5) | 1.526 (CI 95% 0.427–5.723) |
stomach | Â | Â | Â |
   males | 5 (1.6) | 3.11 (1.0) | 1.609 (CI 95% 0.344–8.232) |
   females | 4 (1.3) | 2.59 (0.8) | 1.543 (CI 95% 0.278–9.577) |
liver | Â | Â | Â |
   males | 4 (1.3) | 2.24 (0.7) | 1.786 (CI 95% 0.301–12.53) |
   females | 6 (1.9) | 2.50 (0.8) | 2.396 (CI 95% 0.497–13.83) |
skin 3 | Â | Â | Â |
   males | 5 (1.6) | 3.41 (1.1) | 1.465 (CI 95% 0.326–7.06) |
   females | 3 (1.0) | 3.88 (1.2) | 0.773 (CI 95% 0.137–4.107) |